Henry Meds
Brand Development, Digital Marketing
Our work with Henry Meds focuses on building speed, efficiency, and predictability into GLP-1 patient acquisition. In a category defined by rising competition, regulatory complexity, and volatile media costs, the objective was clear: drive qualified sign-ups fast while laying the groundwork for scalable, lower CAC growth.
Through an accelerated pilot, Mushroom Media deployed a parallelized strategy that combined SEM takeover, early lead generation launches, new paid channel testing, and creative optimization. The program was designed to generate immediate in-market learnings while establishing a durable performance foundation Henry Meds can scale confidently.
Key Achievement #1
Launched SEM Management from Day 1 with Parallel Audit & Optimization
We assumed full management of Google and Bing Ads immediately, removing downtime typically caused by sequential audits. While campaigns were live, we conducted a tactical audit to identify structural inefficiencies, keyword gaps, and bid strategy improvements, allowing optimization and learning to compound from the first week.
This approach accelerated performance feedback loops and ensured Henry Meds captured demand without pausing spend or momentum.
Key Achievement #2
Built and Activated a Conversion-Focused Lead Generation Engine
We designed and launched static, compliance-aligned landing pages optimized for speed, clarity, and high-intent conversion. Development and creative work ran in parallel with media planning, enabling lead generation campaigns to go live asap.
Key Achievement #3
Executed New Paid Channel Test-and-Learn Framework
To reduce overreliance on SEM and uncover incremental growth opportunities, we identified and launched a new paid acquisition channel. Each channel test was governed by clear CPA guardrails, success benchmarks, and rapid decisioning logic.
Winning channels were scaled; underperformers were sunset quickly, ensuring budget efficiency and strategic clarity by pilot close.
Key Achievement #4
Developed a Modular Creative System for Continuous Optimization
We created a flexible creative framework spanning SEM, paid social, and lead generation placements. Assets were designed to be rapidly refreshed based on performance signals, enabling faster iteration on hooks, offers, and visual treatments.
This system supported ongoing creative testing throughout the pilot, helping Henry Meds adapt messaging in real time as market conditions and audience responses evolved.
Key Achievement #5
Enabled Attribution Visibility & Performance Decisioning
We audited existing tracking and attribution infrastructure, closing known gaps to ensure campaign level visibility from click to lead. This allowed for weekly performance reporting, mid pilot CAC trend analysis, and data backed scale-or-sunset decisions across channels.
Outcome
The accelerated growth pilot delivered immediate market presence, actionable performance data, and a scalable acquisition foundation, positioning Henry Meds to compete aggressively in the GLP-1 category while maintaining operational discipline.
This engagement established the systems, learnings, and creative velocity required to move from testing to sustained growth.
